1 |
1.0 miu il-2 per day |
Human interleukin-2 |
- |
- |
- |
002 [1] 2 💬 |
2 |
2.0 miu il-2 per day |
Human interleukin-2 |
- |
- |
- |
002 [1] 2 💬 |
3 |
Anti-il-20 |
Fletikumab |
[1] D11756 D11756 💬 |
IL20 [1] IL20 💬 |
Cytokine-cytokine receptor interaction [3] Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Viral protein interaction with cytokine and cytokine receptor |
046 [1] 46 💬 |
4 |
Anti-il-20 (109-0012) |
Fletikumab |
[1] D11756 D11756 💬 |
IL20 [1] IL20 💬 |
Cytokine-cytokine receptor interaction [3] Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Viral protein interaction with cytokine and cytokine receptor |
046 [1] 46 💬 |
5 |
Anti-il-23 monoclonal antibody |
- |
- |
- |
- |
096 [1] 96 💬 |
6 |
Anticorpo monoclonale anti il-23 |
- |
- |
- |
- |
096 [1] 96 💬 |
7 |
Anticorpo monoclonale anti-il-23 |
- |
- |
- |
- |
096 [1] 96 💬 |
8 |
Il-2 |
Human interleukin-2 |
- |
- |
- |
002 [6] 2 , 46, 49, 53, 56, 96 💬 |
9 |
Low-dose il-2 |
Human interleukin-2 |
- |
- |
- |
056 [1] 56 💬 |
10 |
Low-dose il-2 administration |
Human interleukin-2 |
- |
- |
- |
096 [1] 96 💬 |
11 |
Recombinant human anti il-22 monoclonal antibody igg1 |
- |
- |
- |
- |
046 [1] 46 💬 |
12 |
Tyf-il-2rg gene-modified autologous stem cells |
- |
- |
- |
- |
065 [1] 65 💬 |
13 |
Uttr1147a, il22-fc, il-22fc |
- |
- |
- |
- |
096 [2] 96, 97 💬 |